Anthony Pius Shen Buys 7,000 Shares of Vitalhub (TSE:VHI) Stock

Vitalhub Corp. (TSE:VHI) Director Anthony Pius Shen bought 7,000 shares of the firm’s stock in a transaction dated Monday, March 30th. The stock was purchased at an average price of C$7.11 per share, for a total transaction of C$49,770.00. Following the transaction, the director owned 12,470 shares of the company’s stock, valued at approximately C$88,661.70. This represents a 127.97% increase in their ownership of the stock.

Vitalhub Stock Performance

Shares of TSE:VHI traded down C$0.08 during trading on Monday, reaching C$6.87. The stock had a trading volume of 273,982 shares, compared to its average volume of 359,123. Vitalhub Corp. has a 1-year low of C$6.67 and a 1-year high of C$14.64. The stock has a market cap of C$434.40 million, a PE ratio of 68.70, a PEG ratio of 1.18 and a beta of 0.65. The business has a fifty day moving average price of C$8.07 and a 200-day moving average price of C$9.29.

Vitalhub (TSE:VHI) last posted its quarterly earnings data on Wednesday, March 18th. The company reported C$0.06 EPS for the quarter. Vitalhub had a return on equity of 2.75% and a net margin of 5.61%.The firm had revenue of C$31.39 million during the quarter. Sell-side analysts expect that Vitalhub Corp. will post 0.2296467 earnings per share for the current year.

Analysts Set New Price Targets

A number of equities analysts recently weighed in on the stock. Royal Bank Of Canada lowered their price target on shares of Vitalhub from C$13.00 to C$12.00 and set an “outperform” rating on the stock in a research report on Monday, January 26th. Raymond James Financial decreased their target price on shares of Vitalhub from C$15.00 to C$11.00 and set an “outperform” rating on the stock in a research note on Tuesday, March 24th. Scotiabank lowered their target price on Vitalhub from C$15.00 to C$12.00 and set an “outperform” rating on the stock in a report on Wednesday, February 4th. Finally, ATB Cormark Capital Markets cut their price target on Vitalhub from C$16.50 to C$15.00 and set an “outperform” rating for the company in a report on Tuesday, March 10th. One investment analyst has rated the stock with a Strong Buy rating and six have given a Buy rating to the company’s stock. According to MarketBeat.com, Vitalhub has a consensus rating of “Buy” and an average price target of C$13.86.

About Vitalhub

Vitalhub Corp is Canada-based firm that develops technology solutions for health and human services providers in the mental health (child through adult), long term care, community health service, home health, social service, and acute care sectors. Its technologies include blockchain, mobile, patient flow, web-based assessment, and electronic health record solutions.